Paravasthu Mukund
Chief Operating Officer
Paravasthu Mukund has filed 4 SEC Form 4 filings (8 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Mar 5, 2026.
On the most recent filing, Paravasthu Mukund is listed as Chief Operating Officer at NovoCure Ltd. Inside the rolling window, Paravasthu Mukund reported no open-market purchases and 4 open-market sales totaling $694K in NVCR. The largest disclosed transaction in the window is a sale of 43,246 NVCR shares on Mar 5, 2026, worth $596K.
Companies traded
Other insiders at NVCR
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$694K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Paravasthu Mukund made?
Paravasthu Mukund has filed 4 SEC Form 4 filings (8 transaction rows) across 1 company since 2025.
Which companies does Paravasthu Mukund trade?
Paravasthu Mukund has filed SEC Form 4 disclosures for 1 company, including NVCR.
When was Paravasthu Mukund's most recent SEC Form 4 filing?
Paravasthu Mukund's most recent SEC Form 4 filing on Tracefour is dated Mar 5, 2026.
What is Paravasthu Mukund's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Paravasthu Mukund is listed as Chief Operating Officer.
What is Paravasthu Mukund's total buy and sell value in the current window?
Inside the rolling retention window, Paravasthu Mukund bought $0 and sold $694K based on SEC Form 4 filings.
What was Paravasthu Mukund's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 43,246 NVCR shares on 2026-03-05, worth $596K, per SEC Form 4 filings.